Catheter Precision today announced that more than 800 procedures have been performed using its VIVO System in the U.S. and Europe. The VIVO (View Into Ventricular Onset) System allows physicians to noninvasively identify an area of ventricular arrhythmia onset. It uses noninvasive 3D imaging that identifies the origin of arrhythmias … [Read more...] about Catheter Precision’s VIVO System treats more than 800 patients
Catheter Precision recently announced it expanded its U.S. customer base for the Vivo non invasive 3D imaging system. Vivo is a non-invasive 3D imaging system that allows physicians to identify the location of arrhythmias pre-procedure. It received FDA clearance at the end of 2020 and was strategically launched in the U.S. in 2021. Vivo has also … [Read more...] about Catheter Precision expands Vivo imaging system customer base in U.S.
Ra Medical Systems today announced it entered a merger agreement with Catheter Precision. Under terms of the agreement, Catheter Precision will become a wholly-owned subsidiary of Ra Medical in a stock-for-stock reverse merger transaction. Upon completion, the combined publicly traded company will focus on the cardiac electrophysiology … [Read more...] about Ra Medical enters agreement to merge with Catheter Precision
Ra Medical Systems today announced a reduction in the exercise price of all existing warrants issued in February and has entered into a non-binding term sheet to merge with Catheter Precision. The price reduction affects all existing warrants issued in the February 2022 public offering, consisting of Series A warrants and Series B warrants, from … [Read more...] about Ra Medical enters agreement to raise $6.2M, plans merger with Catheter Precision